Treatment of Advanced Cutaneous Squamous Cell Carcinomas with Epidermal Growth Factor Receptor Inhibitors

Publisher： Karger

E-ISSN： 1421-9832|227|4|289-294

ISSN： 1018-8665

Source： Dermatology, Vol.227, Iss.4, 2013-11, pp. : 289-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Receptor Overexpression and Genetic Aberrations in Metastatic Squamous-Cell Carcinoma of the Skin

By  

Dermatology, Vol. 202, Iss. 3, 2001-05 ,pp. : 203-206

Karger

Access to resources Recommend Favorite

Bazex Syndrome in Lung Squamous Cell Carcinoma: High Expression of Epidermal Growth Factor Receptor in Lesional Keratinocytes with Th2 Immune Shift

By  

Case Reports in Dermatology, Vol. 8, Iss. 3, 2016-12 ,pp. : 358-362

Karger

Access to resources Recommend Favorite

Density of Demodex folliculorum in Patients Receiving Epidermal Growth Factor Receptor Inhibitors

By  

Dermatology, Vol. 222, Iss. 2, 2011-02 ,pp. : 144-147

Karger

Access to resources Recommend Favorite

Pimecrolimus Cream 1% for the Treatment of Papulopustular Eruption Related to Epidermal Growth Factor Receptor Inhibitors: A Case Series and a Literature Review of Therapeutic Approaches

By  

Dermatology, Vol. 220, Iss. 3, 2010-01 ,pp. : 243-248

Karger

Access to resources Recommend Favorite

Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor

By  

Dermatology, Vol. 225, Iss. 2, 2012-09 ,pp. : 135-140

Karger

Access to resources Recommend Favorite